0001140361-24-031290.txt : 20240625
0001140361-24-031290.hdr.sgml : 20240625
20240625160507
ACCESSION NUMBER: 0001140361-24-031290
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240624
FILED AS OF DATE: 20240625
DATE AS OF CHANGE: 20240625
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BRAWLEY OTIS W
CENTRAL INDEX KEY: 0001213029
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37568
FILM NUMBER: 241068924
MAIL ADDRESS:
STREET 1: 5203 BRISTOL INDUSTRIAL WAY
CITY: BUFORD
STATE: GA
ZIP: 30518
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PDS Biotechnology Corp
CENTRAL INDEX KEY: 0001472091
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 264231384
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 303A COLLEGE ROAD EAST
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 800-208-3343
MAIL ADDRESS:
STREET 1: 303A COLLEGE ROAD EAST
CITY: PRINCETON
STATE: NJ
ZIP: 08540
FORMER COMPANY:
FORMER CONFORMED NAME: Edge Therapeutics, Inc.
DATE OF NAME CHANGE: 20090911
4
1
form4.xml
FORM 4
X0508
4
2024-06-24
0001472091
PDS Biotechnology Corp
PDSB
0001213029
BRAWLEY OTIS W
C/O PDS BIOTECHNOLOGY CORPORATION
303A COLLEGE ROAD EAST
PRINCETON
NJ
08540
true
false
Employee Stock Option (Right to Buy)
2.86
2024-06-24
4
A
0
9000
0
A
2034-06-24
Common Stock
9000
9000
D
The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date.
/s/ Spencer Brown, as Attorney-in-Fact
2024-06-25